NEWTOWN, Pa., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on…
National survey from Alignment Healthcare explores issues preventing seniors from accessing care, provides insights into possible solutions Top 3 Social…
BOSTON, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile…
SAN LEANDRO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in…
NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the discovery, development, and…
DALLAS, Aug. 31, 2022 (GLOBE NEWSWIRE) -- International Esperanza Project (IEP), a Dallas-based nonprofit whose mission is to inspire hope…
BURLINGTON, Mass. and JERUSALEM, Aug. 31, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…
BBS-Bioactive Bone Substitutes Plc, Company Announcement, 31 August 2022 16.00 (CEST) BBS Bioactive Bone Substitutes Oyj - Managers' Transactions ____________________________________________…
BBS-Bioactive Bone Substitutes Plc, Company Announcement, 31 August 2022 16.00 (CEST) BBS Bioactive Bone Substitutes Oyj - Managers' Transactions ____________________________________________…
AUSTIN, Texas, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing a novel oral therapeutic candidate,…